Half of all imaging experts involved in the study reported symptoms such as irritated eyes, ocular fatigue, and headaches, among many other discomforts.

That’s according to a new survey of almost 30,000 consumers, led by Harvard Medical School and published in JAMA Network Open. 

Bio Conscious has announced that its AI-powered Diabits app can predict blood glucose levels a full hour into the future—and it has the data to prove it.

The World Health Organization has had to clarify statements made about the spread of COVID-19 through asymptomatic people.

Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.

Operators who performed at least 16 uLMS-PCIs per year were associated with improved survival.

Like a whirlwind, COVID-19 seemed to appear out of nowhere and completely disrupted the global community. Economies are stressed, industries are experiencing unprecedented changes, and governments are trying to manage it all.

Higher research and development costs are driving a need for pharmaceutical companies to leverage AI to optimize the drug discovery process––and some companies are doing so better than others.

Philanthropic nonprofit Rad-Aid deploys some 12,000 volunteers through outreach programs in 35 countries across Africa, Asia, Europe and the Americas. 

Roughly 5% of such providers are actually seeing patient volumes that are higher than pre-COVID levels, according to a new analysis.